| BMSCs | Bone-marrow mesenchymal stem cells |
| UCSCs | Umbilical cord stem cells |
| ADSCs | Adipose-derived stem cells |
| ISCT | International Society for Cellular Therapy |
| MSCs | Mesenchymal stem cells |
| NK | Natural Killer |
| CFU-F | Clonogenic fibroblast precursor cells |
| GVHD | Graft versus host disease |
| EGFR | Epidermal growth factor receptor |
| IGFR | Insulin growth factor receptor |
| PDGFRα | Platelet-derived growth factor receptor alpha |
| GMP | Good manufacturing practices |
| ATMPs | Advanced therapy medicinal products |
| CGTP | Current Good Tissue Practice |
| FCS | Fetal calf serum |
| DMEM | Dulbecco Modified Eagle Medium |
| BMPs | Bone morphogenetic proteins |
| Runx2 | Runt-related transcription 2 |
| PPARγ2 | Peroxisome proliferators-activated receptor gamma 2 |
| SLE | Systemic lupus erythematosus |
| RH | Rheumatoid arthritis |
| HSCs | Hematopoietic stem cells |
| WOMAC | Western Ontario and McMaster Universities Arthritis Index |
| VAS | Visual analog scale |
| SLEDAI | SLE Disease Activity Index |
| ALS | Amyotrophic lateral sclerosis |
| PD | Parkinson’s disease |
| AD | Alzheimer disease |
| OA | Osteoarthritis |